首页> 外国专利> A METHOD OF EVALUATING THE EFFICIENCY OF TREATMENT OF PATIENTS WITH PULMONARY SARCOIDOSIS OF A II-III STAGE WITH SYSTEMIC CORTICOSTEROIDS

A METHOD OF EVALUATING THE EFFICIENCY OF TREATMENT OF PATIENTS WITH PULMONARY SARCOIDOSIS OF A II-III STAGE WITH SYSTEMIC CORTICOSTEROIDS

机译:评估系统性糖皮质激素II-III期肺结节病患者治疗效果的方法

摘要

A method of evaluating the efficiency of treatment of patients with pulmonary sarcoidosis of a II-III stage with systemic corticosteroids provides dynamic, at least twice, examination of the chest cavity using high-resolution computed tomography. 3 months after the initiation of treatment control examination is performed with recording of results of examination on a digital storage and software processing of the results. Identical axial slices of the initial and control examination are analyzed with calculation of the mean density of the lung parenchyma in areas of their maximum change and the treatment is considered as effective if the average density of lung tissue after 3 months of treatment is less than (-885.9) Hounsfield units, compared to the original data. The treatment is considered ineffective if the average density of lung tissue at a given area, is in the range of (-824.1 to -885.9) Hounsfield units or more than (-824.1) Hounsfield units, compared to the original data, in this case the treatment requires continuation for at least 3 months.
机译:一种评估全身性皮质类固醇激素治疗II-III期肺结节病患者疗效的方法,可以使用高分辨率计算机断层扫描对胸部进行至少两次动态检查。在开始治疗控制后3个月,将检查结果记录在数字存储设备上,并对结果进行软件处理。通过计算最大变化区域内的肺实质的平均密度来分析初次检查和对照检查的相同轴向切片,如果治疗3个月后肺组织的平均密度小于( -885.9)霍恩斯菲尔德单位,与原始数据相比。在这种情况下,如果给定区域的肺组织平均密度在(-824.1至-885.9)霍恩斯菲尔德单位或大于(-824.1)霍恩斯菲尔德单位的范围内,则认为治疗无效该治疗需要持续至少3个月。

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号